Browsing Tag
Healius Limited
1 post
Healius (ASX: HLS) to sell Agilex Biolabs to Novotech for A$160m and moves toward net cash
Healius Limited is selling Agilex Biolabs to Novotech for A$160 million, completing another major portfolio exit as the pathology group moves toward a net-cash balance sheet and concentrates capital on Laverty Pathology, Dorevitch Pathology and Queensland Medical Laboratory.